Detalles de la búsqueda
1.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658905
2.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938166
3.
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Int Urol Nephrol
; 56(2): 499-508, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777995
4.
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.
Eur Urol
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383257
5.
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.
Front Oncol
; 13: 1342367, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38282671
Resultados
1 -
5
de 5
1
Próxima >
>>